학술논문
PAZEC: a Dutch Gynaecological Oncology Group open-label, multicenter, phase II study of pazopanib in metastatic and locally advanced hormone-resistant endometrial cancer.
Document Type
Article
Author
Source
International Journal of Gynecological Cancer; Feb2024, Vol. 34 Issue 2, p239-243, 5p
Subject
Language
ISSN
1048891X